Literature DB >> 14674704

Cardiotrophin-1: expression in experimental myocardial infarction and potential role in post-MI wound healing.

Darren H Freed1, Michael C Moon, Anna M Borowiec, Stephen C Jones, Peter Zahradka, Ian M C Dixon.   

Abstract

Cardiotrophin-1 (CT-1), a member of the IL-6 family of cytokines, has been shown to be elevated in the serum of patients with ischemic heart disease and valvular heart disease, and induces cardiomyocyte hypertrophy in vitro. We investigated expression of CT-1 in post-MI rat heart and the effect of CT-1 on cultured primary adult rat cardiac fibroblasts. Elevated CT-1 expression was observed in the infarct zone at 24 h and continued through 2, 4 and 8 weeks post-MI, compared to sham-operated animals. CT-1 induced rapid phosphorylation of Jak, Jak2, STAT1, STAT3, p42/44 MAPK and Akt in cultured adult cardiac fibroblasts. CT-1 induced cardiac fibroblast protein synthesis and proliferation. Protein and DNA synthesis were dependent on activation of Jak/STAT, MEK1/2, PI3K and Src pathways as evidenced by decreased 3H-leucine and 3H-thymidine incorporation after pretreatment with AG490, PD98059, LY294002 and genistein respectively. Furthermore, CT-1 treatment increased procollagen-1-carboxypropeptide (PICP) synthesis, a marker of mature collagen synthesis. CT-1 induced cell migration of rat cardiac fibroblasts. Our results suggest that CT-1, as expressed in post-MI heart, may play an important role in infarct scar formation and ongoing remodeling of the scar. CT-1 was able to initiate each of the processes considered important in the formation of infarct scar including cardiac fibroblast migration as well as fibroblast proliferation and collagen synthesis. Further work is required to determine factors that induce CT-1 expression and interplay with other mediators of cardiac infarct wound healing in the setting of acute cardiac ischemia and chronic post-MI heart failure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14674704     DOI: 10.1023/a:1027332504861

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  37 in total

1.  Signaling of the cardiotrophin-1 receptor. Evidence for a third receptor component.

Authors:  O Robledo; M Fourcin; S Chevalier; C Guillet; P Auguste; A Pouplard-Barthelaix; D Pennica; H Gascan
Journal:  J Biol Chem       Date:  1997-02-21       Impact factor: 5.157

2.  Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy.

Authors:  Z Sheng; K Knowlton; J Chen; M Hoshijima; J H Brown; K R Chien
Journal:  J Biol Chem       Date:  1997-02-28       Impact factor: 5.157

Review 3.  Cytokines which signal through the LIF receptor and their actions in the nervous system.

Authors:  M Murphy; R Dutton; S Koblar; S Cheema; P Bartlett
Journal:  Prog Neurobiol       Date:  1997-08       Impact factor: 11.685

4.  TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II.

Authors:  Jo El J Schultz; Sandra A Witt; Betty J Glascock; Michelle L Nieman; Peter J Reiser; Stacey L Nix; Thomas R Kimball; Thomas Doetschman
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

Review 5.  Is angiotensin II a proliferative factor of cardiac fibroblasts?

Authors:  Fatiha Bouzegrhane; Gaétan Thibault
Journal:  Cardiovasc Res       Date:  2002-02-01       Impact factor: 10.787

Review 6.  Genistein.

Authors:  Richard A Dixon; Daneel Ferreira
Journal:  Phytochemistry       Date:  2002-06       Impact factor: 4.072

7.  Plasma cardiotrophin-1 following acute myocardial infarction: relationship with left ventricular systolic dysfunction.

Authors:  Suneel Talwar; Iain B Squire; Russell J O'brien; Paul F Downie; Joan E Davies; Leong L Ng
Journal:  Clin Sci (Lond)       Date:  2002-01       Impact factor: 6.124

8.  Subacute and chronic effects of quinapril on cardiac cytokine expression, remodeling, and function after myocardial infarction in the rat.

Authors:  Ge Cheng Wei; Martin G Sirois; Rong Qu; Peter Liu; Jean L Rouleau
Journal:  J Cardiovasc Pharmacol       Date:  2002-06       Impact factor: 3.105

9.  Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells.

Authors:  G Wolf; E G Neilson
Journal:  Am J Physiol       Date:  1990-11

10.  Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats.

Authors:  Alexander Deten; Hans Christian Volz; Wilfried Briest; Heinz-Gerd Zimmer
Journal:  Cardiovasc Res       Date:  2002-08-01       Impact factor: 10.787

View more
  14 in total

1.  Fasudil, a Rho-kinase inhibitor, protects against excessive endurance exercise training-induced cardiac hypertrophy, apoptosis and fibrosis in rats.

Authors:  Tsung-Jung Ho; Chi-Chang Huang; Chih-Yang Huang; Wan-Teng Lin
Journal:  Eur J Appl Physiol       Date:  2011-12-09       Impact factor: 3.078

2.  Changes of collagen metabolism predict the left ventricular remodeling after myocardial infarction.

Authors:  Jirmar Radovan; Pelouch Vaclav; Widimsky Petr; Capek Jan; Andel Michal; Prusa Richard; Pechova Martina
Journal:  Mol Cell Biochem       Date:  2006-08-24       Impact factor: 3.396

3.  The lack of cardiotrophin-1 alters expression of interleukin-6 and leukemia inhibitory factor mRNA but does not impair cardiac injury response.

Authors:  Kurt Gritman; Donna M Van Winkle; Christina U Lorentz; Diane Pennica; Beth A Habecker
Journal:  Cytokine       Date:  2006-12-05       Impact factor: 3.861

4.  Modulation of cardiac fibrosis by Krüppel-like factor 6 through transcriptional control of thrombospondin 4 in cardiomyocytes.

Authors:  Daigo Sawaki; Lianguo Hou; Shota Tomida; Junqing Sun; Hong Zhan; Kenichi Aizawa; Bo-Kyung Son; Taro Kariya; Eiki Takimoto; Kinya Otsu; Simon J Conway; Ichiro Manabe; Issei Komuro; Scott L Friedman; Ryozo Nagai; Toru Suzuki
Journal:  Cardiovasc Res       Date:  2015-05-17       Impact factor: 10.787

Review 5.  The immune system and cardiac repair.

Authors:  Nikolaos G Frangogiannis
Journal:  Pharmacol Res       Date:  2008-06-24       Impact factor: 7.658

6.  Cardiotrophin-1 maintains the undifferentiated state in skeletal myoblasts.

Authors:  Tetsuaki Miyake; Nezeka S Alli; Arif Aziz; Jennifer Knudson; Pasan Fernando; Lynn A Megeney; John C McDermott
Journal:  J Biol Chem       Date:  2009-05-12       Impact factor: 5.157

Review 7.  Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure.

Authors:  Erik Tandberg Askevold; Lars Gullestad; Christen P Dahl; Arne Yndestad; Thor Ueland; Pål Aukrust
Journal:  Curr Heart Fail Rep       Date:  2014-06

Review 8.  Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease.

Authors:  Siyun Liao; Janet Bodmer; Daniel Pietras; Mohamad Azhar; Tom Doetschman; Jo El J Schultz
Journal:  Dev Dyn       Date:  2009-02       Impact factor: 3.780

9.  Cellular Interplay between Cardiomyocytes and Nonmyocytes in Cardiac Remodeling.

Authors:  Norifumi Takeda; Ichiro Manabe
Journal:  Int J Inflam       Date:  2011-09-18

10.  Cardiotrophin-1 promotes cardiomyocyte differentiation from mouse induced pluripotent stem cells via JAK2/STAT3/Pim-1 signaling pathway.

Authors:  Tong Liu; Ran Zhang; Tao Guo; Sai Ma; Dong Han; Xiu-Juan Li; Yan Jin; Miao-Miao Fan; Ya-Bin Wang; Yun-Dai Chen; Feng Cao
Journal:  J Geriatr Cardiol       Date:  2015-11       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.